The Lancet Infectious Diseases, 17 (2), February 2017 Abstract: Antimicrobial resistance in Neisseria gonorrhoeae is recognised globally as a public health threat. Dual therapy with ceftriaxone and azithromycin has been introduced in Australia and elsewhere as the first-line treatment recommendation for gonorrhoea. While there have been only sporadic reports of ceftriaxone-resistant gonococci...
VAC, 2015/2017 Community members have recently been expressing interest in human papillomavirus vaccines (HPV) in online discussions. Health bodies in both the UK and Ireland have recommended that all gay and bisexual men receive the vaccine in order to reduce their risk of certain cancers. VAC developed a position statement on this issue back in July 2015 in association with Melbourne Sexual...
A sexual health clinic in London has tested drug levels in users of generic PrEP medication bought online and found the drugs are genuine and effective.
Tests found adequate levels of both emtricitabine and tenofovir (used in PrEP medication Truvada) in patients’ blood, and no sample suggesting counterfeit drugs.
Read more here
See conference program here
Guardian, Friday 28 October 2016 05.00 AEDT A male contraceptive jab has been shown to be almost as effective as the female pill in a trial that could pave the way for men and women being able to share equal responsibility for birth control. In the study, 350 men were given injections of hormones that were shown to dramatically lower their sperm count by “switching off” the male reproductive...
SHine SA, October 2016 SHine SA and Family Planning Alliance Australia put in submissions to the TGA for the rescheduling of ulipristal acetate (EllaOne®), a new emergency contraceptive pill in Australia. The rescheduling is from prescription-only to Schedule 3 (available in pharmacies with a pharmacy consultation). This has now been approved, to take place from February 2017. This is an...
Dr Jennifer Gunter, September 10 2016 The Mirena intrauterine system (IUS), the IUD with the hormone levonorgestrel, is a highly effective method of contraception currently approved for five years. Some data suggests that it probably good for six years, but a new study tells us with a good degree of confidence that the Mirena is safe and effective for seven years. The study was funded by UNDP/...